
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 10, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 10, 2024
Language: Английский
Forensic Toxicology, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
0Life, Journal Year: 2025, Volume and Issue: 15(3), P. 403 - 403
Published: March 4, 2025
During the coronavirus disease 2019 (COVID-19) pandemic, several studies highlighted a worse prognosis for patients with alterations in liver function tests, especially those pre-existing diseases. However, further are needed to define long-term impact of COVID-19 pandemic on Long encompasses wide range signs and symptoms, including exacerbations chronic conditions or new onset developed after acute phase. Therefore, effects extensively include hepatic manifestations. The co-expression angiotensin-converting receptor 2 (ACE2) transmembrane serine protease (TMPRSS2) has been demonstrated also enterocytes, cholangiocytes, hepatocytes. Studies post-COVID-19 sequelae have shown presence steatosis necroinflammation liver, concomitantly an alteration inflammation, cytolysis cholestasis indices. Some increased risk hepatobiliary pathologies, secondary biliary cholangitis worsening severity metabolic-associated fatty (MASLD). Based these premises, this review aims provide overview pathophysiological mechanisms contributing COVID-19-related damage; explore its implications inflammation fibrosis, particular focus MASLD metabolic dysfunction-associated steatohepatitis (MASH); analyze short- sequelae. A literature search was conducted using PubMed database relevant published English.
Language: Английский
Citations
0Life, Journal Year: 2025, Volume and Issue: 15(5), P. 726 - 726
Published: April 30, 2025
The Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), disproportionately affects individuals with diabetes mellitus (DM) exacerbating cardiovascular and renal complications. This increased risk is mediated through immune dysfunction, chronic inflammation, hyperglycemia, dysregulation of renin-angiotensin system dysregulation, endothelial hypercoagulability. Epidemiological studies indicate a two-fold stroke end-stage disease in SARS-CoV-2-infected diabetes, along 60% higher disease. While antidiabetic therapies like sodium-glucose cotransporter-2 inhibitors glucagon-like peptide-1 receptor agonists show potential protective effects, insulin use hospitalized patients linked to mortality. Vaccination crucial reducing severe COVID-19 outcomes mitigating post-infection complications, including new-onset diabetes. concerns exist regarding vaccine-associated nephropathy thromboembolic events, these risks are thought be minimal compared the benefits. As shifts an endemic phase, long-term DM remain uncertain, highlighting urgent need for continued research targeted management strategies.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 10, 2024
Language: Английский
Citations
0